alexa The Global Burden Of Hepatitis In Relation To Sustainable Development Goals - 2030 Targets
ISSN: 2167-0889

Journal of Liver
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

CO-ORGANIZED EVENT: 5th World Congress on Hepatitis & Liver Diseases & 2nd International Conference on Pancreatic Cancer & Liver Diseases
August 10-12, 2017 London, UK

Ruchika Sharma, Seth Kuranz and Michael Hughes
Decision Resources Group, USA
Posters & Accepted Abstracts: J Liver
DOI: 10.4172/2167-0889-C1-015
Abstract
Introduction: Despite being an international public health challenge, hepatitis has not been prioritized until recently. The WHO estimates 130-150 million people worldwide living with chronic hepatitis C virus (HCV) infection and the number is increasing despite improved treatment. In 2016, the WHO released a global health sector strategy on viral hepatitis based on the Sustainable Development Goals 2030 report. It enlists targets to be achieved about HCV incidence, diagnosis and treatment, taking 2015 as the base year. This analysis aims to understand the global impact of successful achievement of the WHO targets on viremic prevalent cases. Methods: HCV viremia is defined as the presence of HCV RNA in the serum. A systematic review of published literature was carried out to extract prevalence, incidence and genotype distribution data for 45 countries, in addition to an analysis of NHANES data. Extracted estimates were trended to 2015 based on current diagnosis and drug treatment scenarios. When country-specific studies were unavailable, results were extrapolated from studies based on comparable populations. When gender-specific results were unavailable, gender-specific results from other studies were used after making any appropriate adjustments to reflect differences in age-adjusted risk. Percentage changes according to the WHO targets were applied to 2015 to arrive at the number of cases in 2020 and 2030. Results: Between 2015 and 2030, there is a considerable decrease in the number of prevalent viremic cases modeled according to the WHO targets. In 2020, the viremic prevalence will be highest in Africa (1.54) and lowest will be in North America (0.76). In 2030, the viremic prevalence will range from 0.15 in North America to 1.0 in Africa. Conclusion: If the WHO targets are achieved, there would be a considerable decrease in the burden of viremic HCV. Results should be interpreted from a global perspective to better understand inequitable differences in the burden of HCV across geographic regions.
Biography

Ruchika Sharma has joined the DRG Epidemiology team at Bangalore in 2016. She specializes in developing epidemiological forecasts and has worked on indications related to the field of Infectious Disease and Primary Nervous System Epidemiology. Her qualifications include an MPH with special focus on Epidemiology from the Post-Graduate Institute of Medical Education and Research, India and a BS degree in Dental Surgery. Prior to joining DRG she was a Fellow at the National Health Systems Resource Centre. She was also the Resident Dental Surgeon at UCMS, New Delhi.

image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]omicsonline.com

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version